Ro Men's Health, MD-Led Platform

Ro is a New York-based direct-to-consumer healthcare company founded in 2017 that operates a portfolio of condition-specific telehealth brands across men's health (Roman), women's health (Rory), and pharmacy services. The Roman brand, which serves as Ro's men's health offering, was among the first companies to systematically solve the problem of ED medication access: millions of men were prescribed sildenafil and tadalafil at steep brand-name prices while generic equivalents existed but were difficult to access without a physician visit and a pharmacy trip. Roman's original model — online health questionnaire, asynchronous physician review, home delivery of generic ED medication — proved enormously successful and was replicated across hair loss, premature ejaculation, herpes suppression, and testosterone screening. Over time, the company unified its brands under the Ro parent and expanded into weight management through its Ro Body program, which integrates GLP-1 medication access (compounded semaglutide and tirzepatide) with health coaching and nutrition guidance. In January 2026, Ro partnered with Novo Nordisk to offer Wegovy in pill form — the first FDA-approved oral GLP-1 medication — marking a significant expansion of its weight loss offering. Ro's clinical model is asynchronous: patients complete a detailed health questionnaire rather than scheduling a live video appointment, and licensed physicians review responses and issue prescriptions through the platform. This model trades the bidirectional engagement of a live consultation for speed and convenience — most patients receive a prescribing decision within hours. For straightforward conditions like ED or androgenetic alopecia where the clinical decision pathway is well-defined, the model is clinically appropriate and meaningfully more accessible than traditional office visits. The company operates nationwide across the continental United States, though not all treatments are available in every state due to prescribing regulation variation. Ro does not accept insurance; all transactions are cash-pay, with HSA/FSA payments accepted for eligible treatments. Medication is dispensed through Ro Pharmacy, the company's in-house pharmacy infrastructure, which allows end-to-end control over the prescription-to-delivery chain. ED medication access: millions of men were prescribed sildenafil and tadalafil at steep brand-name prices while generic equivalents existed but were difficult to access without a physician visit and a pharmacy trip. Roman's original model — online health questionnaire, asynchronous physician review, home delivery of generic ED medication — proved enormously successful and was replicated across hair loss, premature ejaculation, herpes suppression, and testosterone screening. Over time, the company unified its brands under the Ro parent and expanded into weight management through its Ro Body program, which integrates GLP-1 medication access (compounded semaglutide and tirzepatide) with health coaching and nutrition guidance. In January 2026, Ro partnered with Novo Nordisk to offer Wegovy in pill form — the first FDA-approved oral GLP-1 medication — marking a significant expansion of its weight loss offering. Ro's clinical model is asynchronous: patients complete a detailed health questionnaire rather than scheduling a live video appointment, and licensed physicians review responses and issue prescriptions through the platform. This model trades the bidirectional engagement of a live consultation for speed and convenience — most patients receive a prescribing decision within hours. For straightforward conditions like ED or androgenetic alopecia where the clinical decision pathway is well-defined, the model is clinically appropriate and meaningfully more accessible than traditional office visits. The company operates nationwide across the continental United States, though not all treatments are available in every state due to prescribing regulation variation. Ro does not accept insurance; all transactions are cash-pay, with HSA/FSA payments accepted for eligible treatments. Medication is dispensed through Ro Pharmacy, the company's in-house pharmacy infrastructure, which allows end-to-end control over the prescription-to-delivery chain.